I think LW wants the biceps of big pharma to take this to market. I remember reading somewhere about how speed to market was very important to them and overall access through already having global outreach.
If a deal is done my only concern is the that price tag will reflect where the drugs evidence is to date and not its propensity to address other conditions not yet tested. With new addressable conditions being discovered adds continued growth in MC.
Exciting times indeed.
Deal Pending, page-176
-
- There are more pages in this discussion • 185 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.59 |
Change
0.380(2.50%) |
Mkt cap ! $1.992B | |||
| Open | High | Low | Value | Volume |
| $15.51 | $15.82 | $15.46 | $11.26M | 722.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 696 | $15.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.67 | 6942 | 8 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |